Nisa Investment Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.8M Sell
74,490
-6,657
-8% -$2.19M 0.08% 154
2025
Q4
$28.4M Buy
81,147
+1,917
+2% +$648K 0.09% 130
2025
Q3
$25.6M Sell
79,230
-3,579
-4% -$1.11M 0.1% 136
2025
Q2
$32.2M Sell
82,809
-49,575
-37% -$19.9M 0.15% 113
2025
Q1
$57.6M Sell
132,384
-67,054
-34% -$26.9M 0.29% 54
2024
Q4
$73.6M Buy
199,438
+117,473
+143% +$49.2M 0.29% 46
2024
Q3
$42.6M Sell
81,965
-5,085
-6% -$2.72M 0.25% 81
2024
Q2
$47.2M Sell
87,050
-11,985
-12% -$6.34M 0.3% 61
2024
Q1
$51.4M Buy
99,035
+10,337
+12% +$5.14M 0.33% 59
2023
Q4
$41.8M Sell
88,698
-1,209
-1% -$559K 0.3% 68
2023
Q3
$39.1M Sell
89,907
-334
-0.4% -$151K 0.3% 67
2023
Q2
$40.1M Sell
90,241
-7,365
-8% -$3.4M 0.29% 69
2023
Q1
$44.9M Sell
97,606
-4,456
-4% -$2.12M 0.35% 58
2022
Q4
$52.4M Sell
102,062
-2,961
-3% -$1.5M 0.41% 47
2022
Q3
$47.9M Sell
105,023
-284
-0.3% -$136K 0.41% 46
2022
Q2
$50.8M Buy
105,307
+5,424
+5% +$2.68M 0.44% 45
2022
Q1
$49.1M Buy
+99,883
New +$45.7M 0.35% 62
2021
Q4
Sell
-113,627
Closed -$42.4K 2267
2021
Q3
$42.4K Buy
113,627
+500
+0.4% +$190K 0.26% 79
2021
Q2
$43.2K Sell
113,127
-18,655
-14% -$7.13M 0.27% 77
2021
Q1
$47.3K Buy
131,782
+20,797
+19% +$6.69M 0.3% 65
2020
Q4
$35.6M Buy
110,985
+1,673
+2% +$513K 0.23% 100
2020
Q3
$29.4M Sell
109,312
-8,455
-7% -$2.27M 0.24% 96
2020
Q2
$31M Buy
117,767
+1,156
+1% +$308K 0.28% 77
2020
Q1
$26.5M Sell
116,611
-1,800
-2% -$491K 0.29% 78
2019
Q4
$35.8M Sell
118,411
-4,359
-4% -$1.2M 0.31% 71
2019
Q3
$29.5M Sell
122,770
-2,745
-2% -$752K 0.26% 80
2019
Q2
$35.4M Sell
125,515
-9,845
-7% -$2.69M 0.34% 60
2019
Q1
$38.8M Buy
135,360
+3,878
+3% +$1.12M 0.38% 57
2018
Q4
$34.5M Buy
131,482
+775
+0.6% +$213K 0.38% 59
2018
Q3
$35.8M Buy
130,707
+12,672
+11% +$3.29M 0.33% 66
2018
Q2
$28.1M Sell
118,035
-705
-0.6% -$163K 0.29% 76
2018
Q1
$26.5M Sell
118,740
-8,827
-7% -$2.07M 0.28% 81
2017
Q4
$28.7M Buy
127,567
+332
+0.3% +$70.7K 0.3% 77
2017
Q3
$24.2M Buy
127,235
+9,472
+8% +$1.8M 0.27% 84
2017
Q2
$22M Sell
117,763
-1,000
-0.8% -$180K 0.26% 90
2017
Q1
$19.6M Sell
118,763
-960
-0.8% -$153K 0.23% 99
2016
Q4
$17.2M Sell
119,723
-1,396
-1% -$187K 0.21% 113
2016
Q3
$15.2M Sell
121,119
-7,030
-5% -$908K 0.2% 117
2016
Q2
$16.8M Buy
128,149
+550
+0.4% +$75.3K 0.23% 102
2016
Q1
$17.7M Sell
127,599
-1,160
-0.9% -$155K 0.25% 88
2015
Q4
$18M Hold
128,759
0.26% 91
2015
Q3
$18M Sell
128,759
-1,700
-1% -$255K 0.28% 82
2015
Q2
$21.4M Sell
130,459
-1,500
-1% -$240K 0.3% 76
2015
Q1
$20.4M Sell
131,959
-12,350
-9% -$1.76M 0.28% 81
2014
Q4
$18.1M Sell
144,309
-1,950
-1% -$241K 0.25% 90
2014
Q3
$17.5M Sell
146,259
-1,200
-0.8% -$138K 0.25% 94
2014
Q2
$15.9M Sell
147,459
-5,800
-4% -$598K 0.22% 102
2014
Q1
$15.3M Sell
153,259
-400
-0.3% -$36.2K 0.22% 103
2013
Q4
$14.2M Sell
153,659
-1,500
-1% -$133K 0.2% 110
2013
Q3
$13M Sell
155,159
-6,800
-4% -$583K 0.2% 110
2013
Q2
$13.3M Buy
+161,959
New +$12.1M 0.21% 108

Other funds holding ELV

Nisa Investment Advisors's ELV Position: Q1 2026 in Review

Nisa Investment Advisors reduced its Elevance Health (ELV) stake by 8.2% in Q1 2026, selling an estimated $2.19M and leaving 74,490 shares worth $21.8M. The position accounts for 0.08% of the portfolio, ranked #154.

Nisa Investment Advisors first reported a position in ELV in Q2 2013 and has held it in 51 quarters since. The position peaked at $73.6M in Q4 2024. 1,466 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Nisa Investment Advisors held 74,490 shares of Elevance Health worth $21.8M as of Q1 2026.
  • Nisa Investment Advisors sold 6,657 Elevance Health shares in Q1 2026, an estimated $2.19M.
  • Elevance Health made up 0.08% of Nisa Investment Advisors's portfolio in Q1 2026, its #154 holding.
  • Nisa Investment Advisors first reported a position in Elevance Health in Q2 2013 and has held it in 51 quarters since.
  • Nisa Investment Advisors's Elevance Health position peaked at $73.6M in Q4 2024.
  • 1,466 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.